-
-
-
-
-
-
-
Xeris Biopharma Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Xeris Pharmaceuticals Announces Full Exercise of Underwriters’ Options to Purchase Additional Shares and Additional Notes
-
-
-
-
-
-
-
Xeris Pharmaceuticals Inc. (XERS) Prices 9M Share Common Offering at $4.15/Sh
-
-
-
-
-
-
-
Xeris Pharmaceuticals Provides a Business Update During Recent Investor Conference
-
-
-
-
-
-
-
Xeris Pharmaceuticals Announces Pricing of Public Offering of Shares of Common Stock
-
-
-
-
-
-
-
Jefferies Starts Xeris Pharmaceuticals (XERS) at Buy
-
-
-
-
-
-
72,322 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

